Accolade Inc (ACCD)
7.51
-0.12
(-1.57%)
USD |
NASDAQ |
May 07, 15:00
Accolade Cash from Investing (TTM): -63.63M for Feb. 29, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -63.63M |
November 30, 2023 | -12.79M |
August 31, 2023 | -10.99M |
May 31, 2023 | -9.333M |
February 28, 2023 | -7.228M |
November 30, 2022 | -5.347M |
August 31, 2022 | -2.715M |
May 31, 2022 | 63.83M |
February 28, 2022 | -263.61M |
Date | Value |
---|---|
November 30, 2021 | -263.57M |
August 31, 2021 | -264.81M |
May 31, 2021 | -330.60M |
February 28, 2021 | -2.423M |
November 30, 2020 | -2.778M |
August 31, 2020 | -3.664M |
May 31, 2020 | -3.95M |
February 29, 2020 | -3.521M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-330.60M
Minimum
May 2021
63.83M
Maximum
May 2022
-69.83M
Average
-7.228M
Median
Feb 2023
Cash from Investing (TTM) Benchmarks
HealthStream Inc | -46.80M |
HealthEquity Inc | -46.07M |
Trxade Health Inc | -0.2757M |
Simulations Plus Inc | -15.94M |
Schrodinger Inc | 25.91M |